Back
Range Cancer Therapeutics ETF Vs. SPDR® S&P Pharmaceuticals ETF Industry Stock Comparison
Sell
44
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.50
Seasonality Move:
-2.75%
Buy
56
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
44.81
Seasonality Move:
-0.34%
Sell
44
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.69. The Score for CNCR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy, Sell or Hold?
- The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $44.87. The Score for XPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- XPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.69
The current trend is moderately bullish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
XPH Stock Price Chart
What is SPDR® S&P Pharmaceuticals ETF's stock price today?
-
The SPDR® S&P Pharmaceuticals ETF share price today is $44.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPH is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 58.29 | Buy |
| Chaikin Money Flow: | 4125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.57 - 15.57) | Buy |
| Bollinger Bands (100): | (13.97 - 15.41) | Buy |
XPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 61.64 | Buy |
| Chaikin Money Flow: | -18510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.45 - 44.57) | Buy |
| Bollinger Bands (100): | (40.19 - 43.39) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.64 | Buy |
| 20-day SMA: | 15.16 | Buy |
| 50-day SMA: | 14.87 | Buy |
| 200-day SMA: | 14.75 | Buy |
| 8-day EMA: | 15.55 | Buy |
| 20-day EMA: | 15.22 | Buy |
| 50-day EMA: | 14.9 | Buy |
| 200-day EMA: | 14.45 | Buy |
XPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.29 | Buy |
| 20-day SMA: | 44.13 | Buy |
| 50-day SMA: | 43.15 | Buy |
| 200-day SMA: | 41.88 | Buy |
| 8-day EMA: | 44.48 | Buy |
| 20-day EMA: | 44.03 | Buy |
| 50-day EMA: | 43.17 | Buy |
| 200-day EMA: | 41.87 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SPDR® S&P Pharmaceuticals ETF Earnings Growth & XPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SPDR® S&P Pharmaceuticals ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||